| LifeSci Advisors Initiates Coverage on Keryx Biopharmaceuticals - MarketWatch (press release) |
|
|
MarketWatch (press release)"Additionally, we believe Zerenex, the company's therapeutic in development for the treatment of patients with end-stage renal disease, may have significant ...Earnings Preview: Keryx Biopharmaceuticals's Quarterly Results will be ... read more |